Home » Topics » Regulatory

Regulatory
RSS

Mexico approves Dengvaxia, world's first dengue vaccine

Dec. 10, 2015

Baxalta's Vonvendi is first FDA-approved recombinant von Willebrand factor

Dec. 9, 2015

Samsung Bioepis obtains Korean approval for Renflexis and updates pipeline status

Dec. 7, 2015

FDA approves Empliciti for previously treated multiple myeloma

Dec. 1, 2015

FDA approves Portrazza for metastatic squamous NSCLC

Nov. 25, 2015

FDA approves Opdivo for renal cell carcinoma

Nov. 24, 2015

Oxaliplatin and capecitabine regimen approved for gastric cancer adjuvant therapy in Japan

Nov. 23, 2015

FDA approves Ninlaro for multiple myeloma

Nov. 23, 2015

First FDA approval of naloxone nasal spray for opioid overdose

Nov. 19, 2015

FDA first to approve Darzalex for multiple myeloma

Nov. 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...